ArticleCureus2022

Maternal Serum High-Sensitivity C-Reactive Protein (hsCRP) as a Prognostic Marker of Fetomaternal Outcome in Hypertensive Disorders of Pregnancy: A Novel Study.

Ketav Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.